Proposed Role for Neuronal Serotonin N-acetyltransferase
神经元血清素 N-乙酰转移酶的拟议作用
基本信息
- 批准号:6697071
- 负责人:
- 金额:$ 23.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-01-10 至 2006-12-31
- 项目状态:已结题
- 来源:
- 关键词:acyltransferaseantidepressantsbehavior testbiological signal transductioncerebellumenzyme activityenzyme mechanismglutamate receptorgranule cellhigh performance liquid chromatographylaboratory mouselaboratory ratlipopolysaccharidesmental disorder chemotherapymessenger RNAneuroendocrine systemneurophysiologyneurotransmitter metabolismnitric oxide synthasepineal bodypolymerase chain reactionserotonintetrahydrobiopterintissue /cell culture
项目摘要
DESCRIPTION: (provided by applicant) N-acetylserotonrn (NAS) is synthesized
from serotonin by an action of serotonin N-acetyltransferase (AANAT). Although
evidence of hippocampal and cerebellar localization/synthesis of NAS was
provided several years ago, it is still believed that in mammals, AANAT is
almost exclusively expressed in the pmeal gland and in the retina, and that its
neuronal localization is restricted to the lower organisms, such as the fruit
fly. We recently reported that AANAT mRNA is expressed in the rat hippocampus
and that it is up-regulated by the antidepressant fluoxetine (administered
chronically); others found that NAS possesses antidepressant-like activity in a
rodent behavioral despair test. Furthermore, we a) identified those neurons in
the rat CNS that express AANAT mRNA, including cerebellar granule neurons
(CON), b) established primary CON cultures in which AANAT mRNA is normally
expressed and is up-regulated by isoproterenol, c) demonstrated that CON
cultures treated with 3H-labeled serotonin synthesize NAS, and d) found that in
these neurons NAS may act as a functional inhibitor of nitric oxide (NO)
synthesis. We hypothesize that NAS can affect neuronal functioning via the
inhibition of NO synthase (NOS) activity and/or expression (possibly by an
action on the synthesis of the NOS cofactor tetrahydrobiopterin BH4), and that
neuronal expression of AANAT could be a target for the action of antidepressant
treatments. These hypotheses will be tested in the following 6 AIMs: (1)
Characterize in primary rat CON cultures andin BV-2 microglial cultures the
pathways involved in NAS-triggered inhibition of NOS, including the synthesis
of tetrahydrobiopterin, BH4; (2) Characterize in vitro the role of AANAT in
metabolizing serotonin into NAS and in the synthesis of BH4 and/or NOS using
cultures from AANAT mutated mice (expressing enzymatically inactive AANAT) and
normal mice; (3) Characterize in AANAT-mutated and normal mice the basal and
the stimulated BH4 and NO synthesis; (4) Characterize in rat CON cultures the
neurotransmitter systems capable of regulating AANAT expression; (5)
Investigate in rats whether antidepressants other than fluoxetine increase the
brain content of AANAT mRNA, and whether all brain regions expressing AANAT and
the pineal glands are equally affected; (6) Characterize whether the
AANAT-mutated mice respond to antidepressant differently from normal mice in a
model of forced swimming. Techniques to be used include: quantitative reverse
transcription/polymerase chain reaction (RT-PCR) and in situ RT-PCR for AANAT
mRNA; assays of NOS activity, nitrite and BH4 contents; and the forced swimming
test. We expect the results to elucidate the role of AANAT/NAS in neuronal
functioning, and in the long term, in the pathobiology of depression.
描述:(由申请人提供)合成n -乙酰- 5 -羟色胺(NAS)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HARI MANEV其他文献
HARI MANEV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HARI MANEV', 18)}}的其他基金
A role for 5-lipoxyegenase in cocaine's actions
5-脂氧合酶在可卡因作用中的作用
- 批准号:
7561691 - 财政年份:2008
- 资助金额:
$ 23.38万 - 项目类别:
A role for 5-lipoxyegenase in cocaine's actions
5-脂氧合酶在可卡因作用中的作用
- 批准号:
7356854 - 财政年份:2008
- 资助金额:
$ 23.38万 - 项目类别:
Proposed Role for Neuronal Serotonin N-acetyltransferase
神经元血清素 N-乙酰转移酶的拟议作用
- 批准号:
7009367 - 财政年份:2002
- 资助金额:
$ 23.38万 - 项目类别:
Proposed Role for Neuronal Serotonin N-acetyltransferase
神经元血清素 N-乙酰转移酶的拟议作用
- 批准号:
6621076 - 财政年份:2002
- 资助金额:
$ 23.38万 - 项目类别:
Proposed Role for Neuronal Serotonin N-acetyltransferase
神经元血清素 N-乙酰转移酶的拟议作用
- 批准号:
6430338 - 财政年份:2002
- 资助金额:
$ 23.38万 - 项目类别:
Proposed Role for Neuronal Serotonin N-acetyltransferase
神经元血清素 N-乙酰转移酶的拟议作用
- 批准号:
6845360 - 财政年份:2002
- 资助金额:
$ 23.38万 - 项目类别:
相似国自然基金
早年心理应激对大鼠抑郁样行为及突触可塑性的影响
- 批准号:81171284
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
相似海外基金
Stratification of depression based on lysophospholipid metabolic disorders and innovative development of novel antidepressants
基于溶血磷脂代谢紊乱的抑郁症分层及新型抗抑郁药的创新开发
- 批准号:
23H02839 - 财政年份:2023
- 资助金额:
$ 23.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The role of antidepressants in central and peripheral myeloid HIV persistence and inflammation
抗抑郁药在中枢和外周髓系 HIV 持续存在和炎症中的作用
- 批准号:
10762810 - 财政年份:2023
- 资助金额:
$ 23.38万 - 项目类别:
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
单相重度抑郁症药物的优化预测治疗 (OPTIMUM-D)
- 批准号:
469292 - 财政年份:2022
- 资助金额:
$ 23.38万 - 项目类别:
Operating Grants
Concomitant use of antidepressants and oral antidiabetic drugs and the risk of hypoglycemia
抗抑郁药和口服抗糖尿病药的同时使用和低血糖的风险
- 批准号:
10679095 - 财政年份:2022
- 资助金额:
$ 23.38万 - 项目类别:
Molecular and behavioural consequences of maternal depression and antidepressant use during pregnancy
孕期母亲抑郁症和抗抑郁药使用的分子和行为后果
- 批准号:
473680 - 财政年份:2022
- 资助金额:
$ 23.38万 - 项目类别:
Fellowship Programs
Concomitant use of antidepressants and oral antidiabetic drugs and the risk of hypoglycemia
抗抑郁药和口服抗糖尿病药的同时使用和低血糖的风险
- 批准号:
10526807 - 财政年份:2022
- 资助金额:
$ 23.38万 - 项目类别:
Reelin, sex, depression, and development of a novel pharmacotherapy and biomarkers
Reelin、性、抑郁症以及新型药物疗法和生物标志物的开发
- 批准号:
477287 - 财政年份:2022
- 资助金额:
$ 23.38万 - 项目类别:
Operating Grants
The Effect of Energy Spectrum on Light Therapy
能谱对光疗的影响
- 批准号:
466966 - 财政年份:2021
- 资助金额:
$ 23.38万 - 项目类别:
Studentship Programs
Leveraging Rapid-Acting Antidepressants for Personalized Response
利用速效抗抑郁药进行个性化治疗
- 批准号:
10387133 - 财政年份:2021
- 资助金额:
$ 23.38万 - 项目类别:
Utility of the Human Connectome for Predicting Antidepressant Treatment Response
人类连接组用于预测抗抑郁治疗反应的实用性
- 批准号:
454848 - 财政年份:2021
- 资助金额:
$ 23.38万 - 项目类别:
Fellowship Programs